A review of cost-effectiveness of palivizumab for respiratory syncytial virus.

A review of cost-effectiveness of palivizumab for respiratory syncytial virus.

Item
http://www.wikidata.org/entity/Q38058838
Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severityReduced-Dose Schedule of Prophylaxis Based on Local Data Provides Near-Optimal Protection Against Respiratory Syncytial Virus.Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication.Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene.Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy.New insights on the viral and host factors contributing to the airway pathogenesis caused by the respiratory syncytial virus.Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention.Cost-effectiveness of palivizumab compared to no prophylaxis in term infants residing in the Canadian Arctic.RSV: Immunoprophylaxis and non-invasive respiratory support in ex-preterms: A northern UK perspective.Palivizumab for Infants < 29 Weeks in Hong Kong without a Clear-Cut Season for Respiratory Syncytial Virus Infection-A Cost-Effectiveness Analysis.Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.Adherence and outcomes: a systematic review of palivizumab utilization.Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value.Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis.
P2860

A review of cost-effectiveness of palivizumab for respiratory syncytial virus.

Item
http://www.wikidata.org/entity/Q38058838
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A review of cost-effectiveness of palivizumab for respiratory syncytial virus.
@en
type
label
A review of cost-effectiveness of palivizumab for respiratory syncytial virus.
@en
prefLabel
A review of cost-effectiveness of palivizumab for respiratory syncytial virus.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
A review of cost-effectiveness of palivizumab for respiratory syncytial virus
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698